EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
7,854 Shares in Astrazeneca Plc $AZN Bought by Hamel Associates Inc. - Markets Daily
Dorsey & Whitney Trust CO LLC Has $3.94 Million Stake in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times
Type 2 Diabetes breakthrough: No more a jab - AstraZeneca's new oral GLP-1 delivers up to 10.5% weight loss
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
Opinion - Big Pharma lost in court - Congress must not bail it out
Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Jim Cramer on AstraZeneca: "On Track to Hit the Ambitious Long-Term Financial Targets"
WINTON GROUP Ltd Invests $965,000 in Astrazeneca Plc $AZN - Daily Political
Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi‑Year Run?
"Brexit into Asia": British Capital's Shift Towards China
Encouraging trial results for AstraZeneca's new weight-loss pill - Japan Today
Astrazeneca (NYSE:AZN) Given "Buy" Rating at Jefferies Financial Group - Markets Daily
ADA: AZ's oral GLP-1 shows 'competitive efficacy' in phase 2
Jefferies Financial Group Reaffirms "Buy" Rating for AstraZeneca (LON:AZN) - Markets Daily
Deutsche Bank Aktiengesellschaft Reiterates "Sell" Rating for Astrazeneca (NYSE:AZN) - Stock Observer
GSK (GSK) Stock Slides 3% Following $10.6B Nuvalent Acquisition Deal
AstraZeneca's New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar - AOL
6,250 Shares in AstraZeneca PLC $AZNCF Acquired by Monetary Management Group Inc. - Daily Political
AstraZeneca's Elecoglipron Pill: Shattering Weight Loss Records with 10.5% Reduction, ETPharma
AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials | Morningstar
Ionis Appoints Hantson As Board Of Director, Effective Immediately
Quantum Corp (QMCO) Faces Pre-Market Decline of 3.1%
Geode Capital Management LLC Sells 17,227 Shares of Astrazeneca Plc $AZN - Stock Observer
Erste Asset Management GmbH Reduces Stock Position in Astrazeneca Plc $AZN - Stock Observer
O Shaughnessy Asset Management LLC Increases Stock Holdings in Astrazeneca Plc $AZN - Daily Political
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
The European respiratory society guideline for adult bronchiectasis 2025: summary and implementation guide for primary care
Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital
Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
2 FTSE shares for beginners starting an ISA
Capital International Investors Has $2.55 Billion Stock Holdings in Astrazeneca Plc $AZN - Stock Observer
OneAscent Family Office LLC Makes New $613,000 Investment in Astrazeneca Plc $AZN - Stock Observer
Astrazeneca Plc $AZN Shares Purchased by Cibc World Market Inc. - Daily Political
AstraZeneca CEO says AI is reshaping drug development - and helping boost the odds of success
Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge?
AstraZeneca (AZN) Stock: Bernstein Identifies 37% Upside Potential in Overlooked Segment
Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA
AstraZeneca PLC (AZN) Shares Surge 3.1% -- What GF Score of 83 T
AstraZeneca (AZN) Engages with FDA Leadership on Rare Disease Initiatives
Low-dose Zoladex won't be available in Australia from November. What might that mean for you?
Other news to note for June 4, 2026 | BioWorld
GKV Capital Management Co. Inc. Takes $1.58 Million Position in Astrazeneca Plc $AZN - Daily Political
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms
Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes
AZN: Recent Drug Approvals And Key Readouts Will Support Bullish Repricing
AstraZeneca CEO: AI is affecting every part of our company
3 UK shares to consider holding in a Stocks and Shares ISA for a decade
SCS Capital Management LLC Reduces Position in Astrazeneca Plc $AZN - Stock Observer
Martin Investment Management LLC Has $54.32 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Norges Bank Makes New Investment in Astrazeneca Plc $AZN - Stock Observer
Northwestern Mutual Wealth Management Co. Has $15.13 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca (AZN) Benefits from New FDA Guidance on Gene Therapy Development
AstraZeneca (AZN) Reports Promising Phase III Trial Results for Camizestrant
AstraZeneca's (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
ANCA Vasculitis Market to Witness Transformational Growth Opportunities by 2036 - DelveInsight | CSL, Amgen, NS Pharma, Amgen, GlaxoSmithKline, AstraZeneca, Chemocentry, Staidson (Beijing) Biopharma
Regulatory actions for June 2, 2026 | BioWorld
)
ELRIG unveils keynote speakers for Drug Discovery 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort
A homoeriodictyol sodium mouthwash reduces bitterness sensitivity in patients with gynecological cancer receiving carboplatin-based chemotherapy
Asthma Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight
AstraZeneca Scores In Liver Cancer On Its Path To $40 Billion In Oncology Sales
AIM ImmunoTech (AIM) Advances Enrollment in Pancreatic Cancer Trial
AstraZeneca (AZN) Reports Positive Results in Phase III Trial for HCC Treatment
Multiple Clinical Trial Data for Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, to be Presented at ADA 2026 | Morningstar
AstraZeneca's IMFINZI-Based Regimen Cuts Progression Risk By 30% In Liver Cancer Trial
Assessing McCormick (MKC) Valuation After Cindy Hoots Joins The Board Of Directors
Astrazeneca's (AZN) "Buy" Rating Reiterated at Barclays - Daily Political
Regulatory actions for June 1, 2026 | BioWorld
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Citi Keeps Their Buy Rating on AstraZeneca (AZN)
Legal & General Group Plc Trims Stock Holdings in Astrazeneca Plc $AZN - Daily Political
)
Cambridge duo Arm and AstraZeneca rewrite corporate history
AstraZeneca (AZN) Gains Approval for Imfinzi in Bladder Cancer Treatment
25,037 Shares in Astrazeneca Plc $AZN Purchased by SBI Okasan Asset Management Co.Ltd. - Stock Observer
Thoroughbred Financial Services LLC Makes New $1.49 Million Investment in AstraZeneca PLC $AZNCF - Stock Observer
CelLBxHealth signs master services agreement with AstraZeneca
AZN Gains FDA Approval for New Bladder Cancer Treatment
Texas Capital Bank Wealth Management Services Inc Acquires Shares of 3,416 Astrazeneca Plc $AZN - Daily Political
What McCormick (MKC)'s Move to Add a Digital and AI Strategist to Its Board Means for Shareholders - Simply Wall St News
AstraZeneca's durvalumab approved in U.S. for NMIBC patients
AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
Simple Blood Count May Help Predict Flare-Up Risk in Asthma | MDedge
Sun Pharmaceuticals Industries Ltd Futures Share Price & Chart Today | IIFL Capital
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results
AstraZeneca (AZN) Receives FDA Approval for Imfinzi in Bladder Cancer Treatment
AstraZeneca (AZN) Gains FDA Approval for Imfinzi in Bladder Cancer Treatment
AstraZeneca (AZN) Secures U.S. Approval for Imfinzi Combination Therapy
AstraZeneca: Oncology and Rare Disease Data at ASCO 2026
Cary Street Partners Financial LLC Makes New Investment in AstraZeneca PLC $AZNCF - Zolmax
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
AZN's Patent Granted in Canada Strengthens Position in Male Infertility Treatment
FDA delays ruling on AstraZeneca drug after negative adcomm vote
William Blair Investment Management LLC Raises Stake in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca News
Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain
Phased Economic Pressure on Iran: A Strategy to Reopen the Strait of Hormuz
US Strikes Iran Again: Military Pressure Falls Short of Diplomatic Breakthrough
Hormuz Strait Reopens: Shifting Oil Market Dynamics and OPEC's Weakening Grip
Oracle Exceeds Q4 Expectations Driven by AI, but Massive Capex Sparks Investor Concerns
US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreUS Labor Statistics Nominee Affirms Data Integrity Amid Funding and Participation Challenges
As SpaceX, OpenAI, and Anthropic Approach IPOs: New Capital Flows and Sector Reshaping
UAE-Iran High-Level Talks Signal Shift Towards Regional De-escalation Amidst Tensions
SK Hynix Pivots NAND Competition to Material Innovation with 375-Layer Chip
